ロード中...
Which induction chemotherapy regimen followed by cisplatin-based concurrent chemoradiotherapy is the best choice among PF, TP and TPF for locoregionally advanced nasopharyngeal carcinoma?
BACKGROUND: Which induction chemotherapy (IC) regimen followed by cisplatin-based concurrent chemoradiotherapy (CCRT) is the best choice among PF (cisplatin and 5-fluorouracil), TP (docetaxel and cisplatin) and TPF (docetaxel, cisplatin, and 5-fluorouracil) remains controversial in locoregionally ad...
保存先:
| 出版年: | Ann Transl Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6462656/ https://ncbi.nlm.nih.gov/pubmed/31019954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.02.15 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|